Therapeutic targeting of tumour myeloid cells
AstraZeneca (United Kingdom) · AstraZeneca (Singapore) · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
277
total citations
- FWCI
- 43.16
- Percentile
- 100%
- References
- 263
Citations per year
Authors
5- STSimon T. BarryCorresponding
AstraZeneca (United Kingdom), AstraZeneca (Singapore), AstraZeneca (Germany)
- DIDmitry I. Gabrilovich
AstraZeneca (United States)
- OJOwen J. Sansom
Cancer Research UK Scotland Institute, University of Glasgow
- ADAndrew D. Campbell
Cancer Research UK Scotland Institute
- JPJennifer P. Morton
Cancer Research UK Scotland Institute, University of Glasgow
Topics & keywords
Topics
Keywords
- Myeloid
- Context (archaeology)
- Cancer research
- Immunology
- Myeloid cells
- Myeloid leukemia
- Medicine
- Biology
No related works found for this paper.